Prevalence of atrial arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis

P Rujirachun, P Wattanachayakul… - Journal of …, 2020 - journals.lww.com
Methods A comprehensive literature review was conducted by searching for published
articles indexed in MEDLINE and EMBASE databases from inception through to 22 …

Bradyarrhythmias in arrhythmogenic right ventricular cardiomyopathy

E Liang, L Wu, S Fan, X Li, F Hu, L Zheng, X Fan… - The American Journal of …, 2019 - Elsevier
Less is known about bradyarrhythmias in arrhythmogenic right ventricular cardiomyopathy
(ARVC). This cross-sectional study aimed to assess the prevalence and clinical significance …

Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment

R Cardona‐Guarache, M Åström‐Aneq… - Journal of …, 2019 - Wiley Online Library
Introduction The clinical role of atrial arrhythmias (AA) in arrhythmogenic right ventricular
cardiomyopathy (ARVC) and the echocardiographic variables that predict them are not well …

Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis

LP Bosman, A Sammani, CA James, J Cadrin-Tourigny… - Heart rhythm, 2018 - Elsevier
While many studies evaluate predictors of ventricular arrhythmias in arrhythmogenic right
ventricular cardiomyopathy (ARVC), a systematic review consolidating this evidence is …

[HTML][HTML] Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy

N Kikuchi, T Shiga, A Suzuki, N Hagiwara - IJC Heart & Vasculature, 2020 - Elsevier
Abstract Background Atrial tachyarrhythmias (ATAs) are associated with an increased risk of
incident heart failure (HF). The aim of this study was to evaluate the incidence of ATAs and …

Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy

C Cappelletto, C Gregorio, G Barbati, S Romani… - International Journal of …, 2021 - Elsevier
Objectives The aim of our study was to investigate the benefit of antiarrhythmic drugs (AAD)-
beta-blockers, sotalol or amiodarone-in a cohort of Arrhythmogenic Right Ventricular …

Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis

TA Agbaedeng, KA Roberts, L Colley, JJ Noubiap… - EP …, 2022 - academic.oup.com
Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle
abnormality, is a major cause of sudden cardiac death (SCD). However, the burden of SCD …

High arrhythmic burden but low mortality during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy

A Martin, J Crawford, JR Skinner, W Smith - Heart, Lung and Circulation, 2016 - Elsevier
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with a
high incidence of ventricular tachyarrhythmia and sudden death. The mainstay of …

Atrial fibrillation as a clinical characteristic of arrhythmogenic right ventricular cardiomyopathy: Experience from the Nordic ARVC Registry

MA Baturova, KH Haugaa, HK Jensen… - International journal of …, 2020 - Elsevier
Background Recent studies in arrhythmogenic right ventricular cardiomyopathy (ARVC)
patients have drawn attention to atrial fibrillation (AF) as an arrhythmic manifestation of …

Risk score for the exclusion of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy at first presentation

AS Vischer, S Castelletti, P Syrris, R Bastiaenen… - International journal of …, 2019 - Elsevier
Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically determined
heart muscle disorder associated with an increased risk of life-threatening arrhythmias in …